G dasatinib, nilotinib, cabozantinib, pazopanib, ponatinib, crenolanib, sorafenib, and others, have already been investigated in
G dasatinib, nilotinib, cabozantinib, pazopanib, ponatinib, crenolanib, sorafenib, and others, have already been investigated in individuals with advanced GIST. A few of them are advised after failure of authorized therapies…